منابع مشابه
Vaccine against tuberculosis: what’s new?
BACKGROUND one of the World Health Organization Millennium Development Goal is to reduce tuberculosis incidence by 2015. However, more of 8.5 million tuberculosis cases have been reported in 2011, with an increase of multidrug-resistant strains. Therefore, the World Health Organization target cannot be reach without the help of a vaccine able to limit the spread of tuberculosis. Nowadays, bacil...
متن کاملTowards new tuberculosis drugs.
The need for better drugs to treat tuberculosis has never been greater. Despite insufficient funding for discovery research, intensive efforts have been made to find and develop new lead compounds capable of reducing the duration of the present treatment known as DOTS (directly observed therapy short course), from 6 to under 4 months. This minireview describes the progress achieved during the l...
متن کاملNew type of tuberculosis vaccine developed
Health[1] Health[1]Biotechnology [2]Diseases [3]Health [4]Medicine [5]The Body [6]Denmark [7]Videnskab.dk [8] Danish scientists have developed a new vaccine against tuberculosis. The vaccine was created in an entirely new way and may potentially save millions of lives, say the researchers. Tuberculosis annually kills some 1.4 million people, making it one of the world’s deadliest diseases. This...
متن کاملBCG vaccine and pulmonary tuberculosis
Tuberculosis (TB) is one of the most important public health problems in the world and has been declared as a global emergency by the World Health Organization (WHO) in 1993. Bacillus Calmette-Guérin (BCG) is one of the first developed vaccines to prevent TB. Unfortunately, BCG vaccine has had a limited duration of protection and has shown controversial and variable levels of efficacy, especial...
متن کاملThe quest for a new vaccine against tuberculosis.
Tuberculosis (TB) is still one of the deadliest human diseases, killing 1,6 million people each year, mostly in developing countries. The vaccine currently used, Bacille Calmette and Guerin (BCG), is effective in preventing the most severe disseminated forms of disease in children and newborns, but its efficacy against active TB in adults has been challenged by several clinical studies. It is a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines
سال: 2010
ISSN: 1554-8600,1554-8619
DOI: 10.4161/hv.6.4.10711